Stage‐Adaptive Bilayer Hydrogel Coordinates Photodynamic Antibacterial Therapy with Engineered Extracellular Vesicle–Mediated Immunomodulation in Infected Diabetic Wounds
- 1The Second Affiliated Hospital of Kunming Medical University Kunming Yunnan China
- 2Kunming Medical University Kunming Yunnan China
Abstract
During the early phase of treatment, infected diabetic wounds require rapid bacterial control, whereas subsequent healing benefits from relief of persistent oxidative stress and inflammation, resulting in distinct and partly opposing redox demands over time. We therefore developed a stage‐adaptive bilayer hydrogel that separates photodynamic antibacterial therapy from engineered small extracellular vesicle (sEV) delivery. The wound‐contacting layer contains chlorin e6 (Ce6), while the ROS‐responsive upper layer scavenges ROS and retains miR‐146a‐enriched sEVs carrying a human CD64‐recognition module. The bilayer architecture limited premature release of sEV‐associated particles during photodynamic treatment but allowed substantial release thereafter, with key vesicle‐associated features preserved after irradiation. In human macrophages, engineered sEVs increased intracellular miR‐146a, reduced IRAK1 abundance and NF‐κB p65 phosphorylation, decreased CD86, and increased CD206. These effects were partly weakened by CD64 blockade. In infected diabetic wounds, Bil‐Gel@miR‐sEVs reduced bacterial burden and oxidative stress, suppressed IRAK1/NF‐κB‐associated inflammatory signaling, shifted macrophage‐associated markers toward a repair‐associated pattern, and improved epithelial, vascular, and matrix reconstruction. This bilayer design therefore links early infection control with later immunoregulation and tissue repair within one biomaterial.
Related
- A let-7a-5p-engineered extracellular vesicle-laden bioactive scaffold promotes immunomodulation and regeneration of segmental tracheal defects.
- Nanostructured Hybrid Matrix Device: An Engineered Approach for Localized Photodynamic Therapy in 9L/lacZ Cell Models
- A biomimetic nanoparticle coordinates antibacterial and immunomodulatory functions to promote periodontal regeneration
- Natural polysaccharide-engineered POP@ZIF-67 nanoparticles coordinate antibacterial activity, macrophage polarization, and osteogenesis for chronic osteomyelitis therapy.
- Commentary: An engineered and scalable human cell-derived extracellular matrix demonstrates advantages over recombinant collagen in biomimicry and wound healing
BibTeX
@article{zhang2026stageadaptive,
title = {{Stage‐Adaptive Bilayer Hydrogel Coordinates Photodynamic Antibacterial Therapy with Engineered Extracellular Vesicle–Mediated Immunomodulation in Infected Diabetic Wounds}},
author = {Gaofei Zhang and Boheng Zhu and Shihao Deng and Pan Du and Jun Pu and Xin Wang and Shuqian Dou and Yifei Wang and Wenjun Liu},
journal = {Advanced Science},
year = {2026},
month = nov,
doi = {10.1002/advs.78491},
url = {https://doi.org/10.1002/advs.78491},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Stage‐Adaptive Bilayer Hydrogel Coordinates Photodynamic Antibacterial Therapy with Engineered Extracellular Vesicle–Mediated Immunomodulation in Infected Diabetic Wounds
AU - Gaofei Zhang
AU - Boheng Zhu
AU - Shihao Deng
AU - Pan Du
AU - Jun Pu
AU - Xin Wang
AU - Shuqian Dou
AU - Yifei Wang
AU - Wenjun Liu
PY - 2026
DA - 2026/11/10
JO - Advanced Science
DO - 10.1002/advs.78491
UR - https://doi.org/10.1002/advs.78491
AB - During the early phase of treatment, infected diabetic wounds require rapid bacterial control, whereas subsequent healing benefits from relief of persistent oxidative stress and inflammation, resulting in distinct and partly opposing redox demands over time. We therefore developed a stage‐adaptive bilayer hydrogel that separates photodynamic antibacterial therapy from engineered small extracellular vesicle (sEV) delivery. The wound‐contacting layer contains chlorin e6 (Ce6), while the ROS‐responsive upper layer scavenges ROS and retains miR‐146a‐enriched sEVs carrying a human CD64‐recognition module. The bilayer architecture limited premature release of sEV‐associated particles during photodynamic treatment but allowed substantial release thereafter, with key vesicle‐associated features preserved after irradiation. In human macrophages, engineered sEVs increased intracellular miR‐146a, reduced IRAK1 abundance and NF‐κB p65 phosphorylation, decreased CD86, and increased CD206. These effects were partly weakened by CD64 blockade. In infected diabetic wounds, Bil‐Gel@miR‐sEVs reduced bacterial burden and oxidative stress, suppressed IRAK1/NF‐κB‐associated inflammatory signaling, shifted macrophage‐associated markers toward a repair‐associated pattern, and improved epithelial, vascular, and matrix reconstruction. This bilayer design therefore links early infection control with later immunoregulation and tissue repair within one biomaterial.
SN - 2198-3844
ER -